Chronic Respiratory Diseases Treatment Market Trends

Growth Drivers

Increasing Cases of COVID-19 to Increase Demand for Respiratory Disease Drugs

Since the starting of 2020, we have witnessed an exponential growth in the number of cases of COVID-19 worldwide. In majority of the cases, patients show symptoms similar to that of respiratory diseases. Thereby, it has increased the demand for respiratory drugs. Increased demand coupled with the necessity of developing a vaccine with drive the respiratory disorders treatment market in upcoming few years.

Increasing Level of Air Pollution to Increase Cases for Respiratory Diseases

Most of the developing countries where rapid industrialization is happening, are witnessing an increase in the level of air pollution which is one of the primary risk factor for respiratory disorders treatment such as COPD and asthma. As per the Global Asthma report, 2018, more than 1 billion people are affected by pulmonary diseases. High level of pollution contributes to the increasing number of respiratory disease patients which can further lead to growth of respiratory disorders treatment market.

Challenges

Lack of Testing Infrastructure to Diagnose Respiratory Disorders Treatment to Hamper Growth

Most of the developing nations do not have good healthcare facilities and they lack in infrastructure and COVID-19 has clearly exposed this limitation. Treatment of any disease starts only when the disease is diagnosed but the lack of testing infrastructure makes it extremely difficult to diagnose diseases among countries with high population. This limitation may hamper the market growth for respiratory diseases.

Side Effects of Drugs to Hamper Growth

Most of the respiratory disease drugs have side effects and hence people hesitate in using these drugs. So there is a challenge in-front of drug manufacturing companies to innovate and prepare drug which have either no side effects or they have only a few non-severe side effects.